GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Total Stockholders Equity

K Pharma (TSE:4896) Total Stockholders Equity : 円2,871 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma Total Stockholders Equity?

K Pharma's Total Stockholders Equity for the quarter that ended in Mar. 2024 was 円2,871 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. K Pharma's Book Value per Share for the quarter that ended in Mar. 2024 was 円247.43. The ratio of a company's debt over equity can be used to measure how leveraged this company is. K Pharma's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

K Pharma Total Stockholders Equity Historical Data

The historical data trend for K Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Total Stockholders Equity Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
Total Stockholders Equity
178.89 1,336.26 3,104.77

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial 1,336.26 1,851.04 1,734.48 3,104.77 2,871.32

K Pharma  (TSE:4896) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

K Pharma's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(2871.32-0)/11.6046
=247.43

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

K Pharma's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 2871.32
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

K Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of K Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

K Pharma (TSE:4896) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Total Stockholders Equity
Comparable Companies
TSE:7776 TSE:4888 TSE:4594 TSE:4598 TSE:4588 TSE:4891 TSE:2370 TSE:3750 TSE:4583 TSE:4564 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
Website
https://en.kpharma.co.jp
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines